No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 |
18f-av-1451 |
Flortaucipir f-18 |
- |
- |
- |
[3] 5, 7, 127 |
2 |
18f-ro6958948 |
- |
- |
- |
- |
[3] 5, 7, 127 |
3 |
Abbv-8e12 |
- |
- |
- |
- |
[2] 5, 7 |
4 |
Anti-parkinson medication |
- |
- |
- |
- |
[4] 5, 6, 7, 17 |
5 |
Biib092 |
- |
- |
- |
- |
[3] 5, 7, 127 |
6 |
Botulinum toxin type a |
Botulinum toxin type a |
D00783 |
[1] SNAP25 |
[2] Insulin secretion, Synaptic vesicle cycle |
[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
7 |
Davunetide |
Davunetide |
D09401 |
- |
- |
[3] 5, 7, 127 |
8 |
Davunetide (al-108, nap) |
Davunetide |
D09401 |
- |
- |
[3] 5, 7, 127 |
9 |
Dopamine |
Dopamine |
D00633, D07870 |
[5] DRD1, DRD2, DRD3, DRD4, DRD5 |
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
[3] 6, 7, 74 |
10 |
Florbetapir f18 |
- |
- |
- |
- |
[2] 5, 7 |
11 |
Flutemetamol |
Flutemetamol |
- |
- |
- |
[5] 5, 6, 7, 17, 127 |
12 |
Leucine |
L-leucine |
D00030 |
- |
- |
[7] 5, 6, 7, 127, 283, 284, 299 |
13 |
Lithium |
Lithium citrate |
D04749 |
- |
- |
[4] 2, 5, 7, 8 |
14 |
Nt 101 |
- |
- |
- |
- |
[4] 5, 6, 7, 17 |
15 |
Raclopride |
Raclopride |
- |
- |
- |
[4] 5, 6, 7, 17 |
16 |
Tpi 287 2 mg/m2 |
- |
- |
- |
- |
[2] 5, 7 |
17 |
Tpi-287 20 mg/m2 |
- |
- |
- |
- |
[2] 5, 7 |
18 |
Tpi-287 6.3 mg/m2 |
- |
- |
- |
- |
[2] 5, 7 |
19 |
Vizamyl |
- |
- |
- |
- |
[3] 5, 7, 127 |
20 |
Vizamyl (flutemetamol(f-18)) |
Flutemetamol |
- |
- |
- |
[3] 5, 7, 127 |
21 |
Xeomin |
Botulinum toxin type a |
D00783 |
[1] SNAP25 |
[2] Insulin secretion, Synaptic vesicle cycle |
[7] 5, 6, 7, 13, 15, 17, 113 |